PEDIATRIC CLINICAL RESEARCH:Specializing in NICU and PICU populations

Because children respond to medical treatments differently than
adults, pediatric clinical trials should be different from adult
trials. It’s just good science: for optimum safety and efficacy, trial
design and execution should match the physiology and needs of
the patient population, especially children. Paidion combines
pediatric clinical pharmacology expertise with innovative
pediatric regulatory strategies and trial methodologies to provide
best-in-class service to our drug development partners. Our
experienced team provides a deep and broad understanding of
practice norms and patterns, patient procedures, standard drug
use, and expected complications of related ages/gestational ages.

Especially now, with the recent FDA/EMA mandates requiring a pediatric component to all research efforts, Paidion, a global CRO dedicated exclusively to pediatric clinical research, is the right choice for your clinical research needs.

We’ve all heard the saying, “Children are not little adults.” Never
was this truer than in the clinical research realm. Special
considerations for this dynamic and vulnerable patient
population must be taken into account in the development and
execution of pediatric studies. Key to success are factors
including physiological differences, safe and effective drug
formulations and dosing, operational logistics that account for
families, and the real life challenges of enrollment, compliance
and overall quality.

Paidion Research is expert at maximizing your efforts using pharmacometrics, smart techniques
that optimize opportunities for clinical research with a limited number of children, as well as innovative
regulatory strategies and efficient, effective global execution. Are you ready to meet the new
requirements quickly, efficiently and cost-effectively?
To see how Paidion can successfully partner as your pediatric clinical research provider, contact us.